[Federal Register Volume 67, Number 119 (Thursday, June 20, 2002)]
[Notices]
[Pages 42058-42059]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-15563]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated December 21, 2001, and published in the Federal 
Register on January 8, 2002, (67 FR 922), Cerilliant Corporation, 14050 
Summit Drive 121, P.O. Box 80189, Austin, Texas 78708-0189, 
made application by renewal to the Drug Enforcement Administration to 
be registered as an importer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)..........................  I
Methcathinone (1237)......................  I
N-Ethylamphetamine (1475).................  I
Gamma hydroxybutyric acid (2010)..........  I
Ibogaine (7260)...........................  I
Tetrahydrocannabinols (7370)..............  I
Mescaline (7381)..........................  I
4-Bromo-2,5-dimethoxyamphetamine (7391)...  I
4-Bromo-2,5-dimethoxyphenethylamine (7392)  I
4-Methyl-2,5-dimethoxyamphetamine (7395)..  I
2,5-Dimethoxyamphetamine (7396)...........  I
3,4-Methylenedioxyamphetamine (7400)......  I
3,4-Methylenedioxy-N-ethylamphetamine       I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)..  I
4-Methoxyamphetamine (7411)...............  I
Psilocybin (7437).........................  I
Psilocyn (7438)...........................  I
Heroin (9200).............................  I
Pholcodine (9314).........................  I
Amphetamine (1100)........................  II
Methamphetamine (1105)....................  II
Amobarbital (2125)........................  II
Pentobarbital (2270)......................  II
Cocaine (9041)............................  II
Codeine (9050)............................  II
Etorphine (9056)..........................  II
Dihydrocodeine (9120).....................  II
Oxycodone (9143)..........................  II
Hydromorphone (9150)......................  II
Benzoylecgonine (9180)....................  II

[[Page 42059]]

 
Ethylmorphine (9190)......................  II
Meperidine (9230).........................  II
Methadone (9250)..........................  II
Dextropropoxyphene, bulk (non-dosage        II
 forms) (9273).
Morphine (9300)...........................  II
Thebaine (9333)...........................  II
Levo-alphacetylmethadol (9648)............  II
Oxymorphone (9652)........................  II
------------------------------------------------------------------------

    The firm plans to import small quantities of the listed controlled 
substances for the manufacture of analytical reference standards.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Cerilliant Corporation to import 
the above listed controlled substances is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Cerilliant Corporation to ensure that the 
company's registration is consistent with the public interest. This 
investigation included inspection and testing of the company's physical 
security systems, verification of the company's compliance with state 
and local laws, and a review of the company's background and history. 
Therefore, pursuant to Section 1008(a) of the Controlled Substances 
Import and Export Act and in accordance with Title 21, Code of Federal 
Regulations, Section 1301.34, the above firm is granted registration as 
an importer of the basic classes of controlled substances listed above.

    Dated: June 7, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-15563 Filed 6-19-02; 8:45 am]
BILLING CODE 4410-09-M